Veracyte, Inc.
Veracyte, Inc. (VCYT) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · VCYT · as of Sep 30, 2025
Ownership Breakdown
301
Institutional Holders
▲ 24 vs Q2
$3.08B
Total Inst. Value
▲ $772.78M vs Q2
79.79M
Shares Outstanding
freeFloat 99.47%
89.76M
13F Shares Held
▲ 4.37M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
VCYT largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. services-medical laboratories | 13.05M | 16.69% | 16.69% | $448.08B | Nov 12, 2025 | ▲ 5.32M |
VANGUARD GROUP INC services-medical laboratories | 8.50M | 10.87% | 10.87% | $291.95B | Nov 7, 2025 | ▲ 403.7K |
ARTISAN PARTNERS LIMITED PARTNERSHIP services-medical laboratories | 7.37M | 9.42% | 9.42% | $253.03B | Nov 12, 2025 | ▲ 1.05M |
FMR LLC services-medical laboratories | 6.80M | 8.69% | 8.69% | $233.30B | Nov 13, 2025 | ▼ 1.31M |
ARK INVESTMENT MANAGEMENT LLC services-medical laboratories | 4.47M | 5.71% | 5.71% | $153.31B | Nov 12, 2025 | ▲ 665.7K |
STATE STREET CORP services-medical laboratories | 4.20M | 5.37% | 5.37% | $144.17B | Nov 14, 2025 | ▲ 1.03M |
WELLINGTON MANAGEMENT GROUP LLP services-medical laboratories | 3.37M | 4.31% | 4.31% | $115.80B | Nov 14, 2025 | ▼ 100.5K |
DIMENSIONAL FUND ADVISORS LP services-medical laboratories | 3.12M | 3.99% | 3.99% | $107.04B | Nov 12, 2025 | ▲ 95.7K |
ARROWMARK COLORADO HOLDINGS LLC services-medical laboratories | 2.55M | 3.25% | 3.25% | $87.40B | Nov 14, 2025 | ▼ 33.1K |
GEODE CAPITAL MANAGEMENT, LLC services-medical laboratories | 1.89M | 2.42% | 2.42% | $64.94B | Nov 12, 2025 | ▼ 39.9K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
22
Increased
+10.59M shares8
New Positions
first time holders19
Decreased
−3.51M shares0
Sold Out
fully exitedNet shares change (top 50)
+7.08M
+10.59M / −3.51M
Net new holders
+11
8 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
VCYT insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
3
Buy transactions
18
Sell transactions
0.17
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
McGuire Annie EVP, General Counsel | Jun 2, 2026 | Tax Withhold | 3,292 | $47.80 | $157.4K | 140.4K | Form 4 ↗ |
McGuire Annie EVP, General Counsel | Jun 4, 2026 | Sale | 1,400 | $49.31 | $69.0K | 139.0K | Form 4 ↗ |
McGuire Annie EVP, General Counsel | Jun 4, 2026 | Sale | 1,776 | $50.12 | $89.0K | 137.2K | Form 4 ↗ |
Wygant Jonathan VP, Chief Accounting Officer | Jun 2, 2026 | Tax Withhold | 1,361 | $47.80 | $65.1K | 44.1K | Form 4 ↗ |
Chambers Rebecca Chief Financial Officer | Jun 2, 2026 | Tax Withhold | 3,693 | $47.80 | $176.5K | 176.8K | Form 4 ↗ |
Chambers Rebecca Chief Financial Officer | Jun 4, 2026 | Sale | 1,600 | $49.28 | $78.9K | 175.2K | Form 4 ↗ |
Chambers Rebecca Chief Financial Officer | Jun 4, 2026 | Sale | 1,961 | $50.09 | $98.2K | 173.3K | Form 4 ↗ |
Febbo Phillip G. Chief Scientific & Med Officer | Jun 2, 2026 | Tax Withhold | 3,730 | $47.80 | $178.3K | 149.8K | Form 4 ↗ |
Stapley Marc Chief Executive Officer | Jun 2, 2026 | Tax Withhold | 9,012 | $47.80 | $430.8K | 440.5K | Form 4 ↗ |
Stapley Marc Chief Executive Officer | Jun 4, 2026 | Sale | 138,051 | $50.12 | $6.92M | 440.5K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Veracyte, Inc. (VCYT) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 0.53%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Veracyte, Inc. is BLACKROCK, INC., holding approximately 13.05 million shares — equal to 16.69% of outstanding shares — as of September 30, 2025.
A total of 301 institutional investors currently hold VCYT stock, with a combined institutional value of approximately $3.08 billion as of the most recent 13F filing period.
Frequently asked questions
VCYT ownershipVeracyte, Inc. (VCYT) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is BLACKROCK, INC. with a 16.69% stake. Company insiders hold 0.53%. Data sourced from SEC Form 13F as of September 30, 2025.